Related Experiment Videos
Robustness testing, using experimental design, of a flow-through dissolution method for a product where the actives
1Pharmaceutical Development Sciences, GlaxoWellcome, Temple Hill, Dartford, DA1 5AH, Kent, UK.
International Journal of Pharmaceutics
|November 4, 2000
Summary
This study tested the robustness of a flow-through dissolution method for atovaquone in Malarone tablets. The method proved reliable for most factors, ensuring accurate drug release testing.
Area of Science:
- Pharmaceutical Sciences
- Analytical Chemistry
- Drug Development
Background:
- Atovaquone solubility is suppressed by proguanil hydrochloride in Malarone tablets.
- Coating material insolubility can cause imprecision in dissolution testing.
- Robust dissolution methods are crucial for quality control of multi-drug formulations.
Purpose of the Study:
- To evaluate the robustness of a flow-through dissolution method for atovaquone using experimental design.
- To identify critical method parameters affecting atovaquone dissolution testing.
- To ensure reliable dissolution profiles for Malarone tablets.
Main Methods:
- Application of a quarter fractional two-level factorial design for robustness testing.
- Utilized Ph. Eur./USP Apparatus 4 for flow-through dissolution.
- Assessed six factors across sixteen experiments with six center points.
Main Results:
- The dissolution method demonstrated robustness to minor variations in most factors at 30 minutes and beyond.
- At 15 minutes, sodium hydroxide concentration, pump speed, and flow rate significantly impacted results.
- Atovaquone release reached pharmacopoeial limits (Q=75%) by 45 minutes.
Conclusions:
- The developed flow-through dissolution method is robust for atovaquone, ensuring reliable quality control.
- Specific parameters (NaOH concentration, pump speed, flow rate) require strict control during early dissolution stages.
- This experimental design approach can be adapted for other dissolution testing procedures.